Add to ORKGt a, enter, D 2006 European Society of Cardiology. Published by Elsevier B.V. All rights reserved. levels of health care utilization and thus increasing costs [2]. advances in pharmacological treatment of CHF, a large number of patients will still suffer from dyspnoea, fatigue, diminished exercise capacity and poor quality of life [5,8]. It ing is now bein
Cardiovascular disease has emerged as one of the most prominent causes of morbidity and mortality am...
Pharmacotherapy in heart failure with reduced ejection fraction during the last 20 years, and the wa...
Few conditions in medicine have a prognosis as bleak as chronic heart failure but recent development...
dBackground: Recent registries have shown that recommended drugs for the treatment of chronic heart ...
Ž.Chronic heart failure CHF is a major public health problem with high attendant morbidity and morta...
HF) offici sis o steep increase in the elderly [1]. Ageing of the population, condition associated w...
Evidence-based medicine requires that clinical benefits should be evaluated by 'hard ' end...
Episodes of worsening symptoms and signs characterize the clinical course of patients with chronic h...
INTRODUCTION Most studies on heart failure (HF) management published in 2019 by high-ranking impact ...
Heart failure is becoming, in France as in other countries, a major public health problem, occurring...
As the final pathway for the myriad diseases that affect the heart, the syndrome of heart failure (H...
This editorial refers to $Decreasing one-year mortality and hospitalization rates for heart failure ...
Copyright © 2014 Yanggan Wang et al.This is an open access article distributed under the Creative Co...
Heart failure (HF) remains a major medical problem, and the European Journal of Heart Failure is ded...
The syndrome of heart failure (HF) is a growing epidemic that causes a significant socio-economic bu...
Cardiovascular disease has emerged as one of the most prominent causes of morbidity and mortality am...
Pharmacotherapy in heart failure with reduced ejection fraction during the last 20 years, and the wa...
Few conditions in medicine have a prognosis as bleak as chronic heart failure but recent development...
dBackground: Recent registries have shown that recommended drugs for the treatment of chronic heart ...
Ž.Chronic heart failure CHF is a major public health problem with high attendant morbidity and morta...
HF) offici sis o steep increase in the elderly [1]. Ageing of the population, condition associated w...
Evidence-based medicine requires that clinical benefits should be evaluated by 'hard ' end...
Episodes of worsening symptoms and signs characterize the clinical course of patients with chronic h...
INTRODUCTION Most studies on heart failure (HF) management published in 2019 by high-ranking impact ...
Heart failure is becoming, in France as in other countries, a major public health problem, occurring...
As the final pathway for the myriad diseases that affect the heart, the syndrome of heart failure (H...
This editorial refers to $Decreasing one-year mortality and hospitalization rates for heart failure ...
Copyright © 2014 Yanggan Wang et al.This is an open access article distributed under the Creative Co...
Heart failure (HF) remains a major medical problem, and the European Journal of Heart Failure is ded...
The syndrome of heart failure (HF) is a growing epidemic that causes a significant socio-economic bu...
Cardiovascular disease has emerged as one of the most prominent causes of morbidity and mortality am...
Pharmacotherapy in heart failure with reduced ejection fraction during the last 20 years, and the wa...
Few conditions in medicine have a prognosis as bleak as chronic heart failure but recent development...